Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China

Chin Med J (Engl). 2021 Feb 1;134(5):590-592. doi: 10.1097/CM9.0000000000001347.

Authors

Yi-Ran Si¹, Feng Du², Nan-Lin Hu¹, Xue Wang¹, Jian Yue¹, Pei-Di Jiang¹, Bing-He Xu¹, Peng Yuan¹; Breast Cancer Group, Chinese Association for Clinical Oncologist

Affiliations

¹ National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
² Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, Beijing 100142, China.

No abstract available

MeSH terms

Breast Neoplasms / diagnosis*
Breast Neoplasms / metabolism
COVID-19 / complications*
China / epidemiology
Female
Humans
SARS-CoV-2 / pathogenicity